Evolus, Inc. (EOLS)

USD 11.08

(-5.54%)

Market Cap (In USD)

701.6 Million

Revenue (In USD)

202.08 Million

Net Income (In USD)

-61.68 Million

Avg. Volume

548.45 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.7-17.82
PE
-
EPS
-
Beta Value
1.315
ISIN
US30052C1071
CUSIP
30052C107
CIK
1570562
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. David Moatazedi
Employee Count
-
Website
https://www.evolus.com
Ipo Date
2018-02-08
Details
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.